Y. Ochi

发表

Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism.

S. Nishikawa, H. Yamada, Makoto Tanaka, 2011, Bone.

Effect of Intermittent and Daily Regimens of Minodronic Acid on Bone Metabolism in an Ovariectomized Rat Model of Osteoporosis

H. Yamada, Makoto Tanaka, Y. Ochi, 2014, Calcified Tissue International.

Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.

H. Yamada, Makoto Tanaka, K. Kishikawa, 2008, Bone.

Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys

S. Nishikawa, H. Yamada, Makoto Tanaka, 2019, International journal of rheumatology.

Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.

S. Nishikawa, H. Yamada, Makoto Tanaka, 2016, Bone.

Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats

H. Yamada, A. Imagawa, Makoto Tanaka, 2014, Journal of Bone and Mineral Metabolism.

Joint Degradation in a Monkey Model of Collagen-Induced Arthritis: Role of Cathepsin K Based on Biochemical Markers and Histological Evaluation

N. Amizuka, Minqi Li, S. Nishikawa, 2016, International journal of rheumatology.

Efficacy of ONO-5334, a cathepsin K inhibitor, on bone mass and strength in ovariectomized cynomolgus monkeys

H. Yamada, S. Nishikawa, Y. Hashimoto, 2011 .

Efficacy of ONO-5334, a cathepsin K inhibitor, on bone turnover and cortical geometry in ovariectomized cynomolgus monkeys

S. Nishikawa, Y. Hashimoto, Y. Ochi, 2011 .

ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats

H. Yamada, A. Imagawa, Makoto Tanaka, 2014, Journal of Bone and Mineral Metabolism.

Bile-Pancreatic Juice-Independent Increases in Pancreatic Proteases and Intestinal Cholecystokinin by Dietary Protein in Rats

H. Hara, T. Kasai, Y. Ochi, 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.

S. Yano, T. Maruyama, S. Horie, 2005, Life sciences.

Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats.

S. Nishio, Y. Ueno, Y. Ochi, 1996, Japanese journal of pharmacology.

N-(2-Hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a Novel, Potent, and Selective Acid Pump Antagonist for the Treatment of Gastroesophageal Reflux Disease

N. Takahashi, Hiroyuki Ohshiro, M. Sakakibara, 2009, Journal of Pharmacology and Experimental Therapeutics.

Novel Technique to Reinforce the Weak Point of a Side-to-side Anastomosis

Hironori Tanaka, M. Kimura, Y. Shibata, 2016 .

Changes in messenger RNA of pancreatic enzymes and intestinal cholecystokinin after a 7-day bile-pancreatic juice diversion from the proximal small intestine in rats.

H. Hara, T. Kasai, Y. Ochi, 1997, Bioscience, biotechnology, and biochemistry.

A multiple gastric ulcer case caused by cytomegalovirus infection.

N. Uemura, S. Kishi, M. Matsuda, 1996, The Tokushima journal of experimental medicine.

Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.

Toshitaka Nakamura, Masako Ito, H. Yamada, 2008, Bone.

5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-α]pyridine-8-carboxamide (CJ-033,466), a Novel and Selective 5-Hydroxytryptamine4 Receptor Partial Agonist: Pharmacological Profile in Vitro and Gastroprokinetic Effect in Conscious Dogs

Y. Sugie, Keiko Suzuki, M. Sakakibara, 2008, Journal of Pharmacology and Experimental Therapeutics.

[Pharmacology profile and clinical findings of pregabalin (Lyrica capsule)].

Takuma Harada, A. Arakawa, Y. Ochi, 2010, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys.

S. Nishikawa, H. Yamada, Makoto Tanaka, 2014, Bone.

Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin I2 Analogue) in the Atherosclerotic Rabbit Artery After Angioplasty

S. Okazaki, S. Nishio, Y. Ueno, 1995, Journal of cardiovascular pharmacology.

Cortical bone mineral density is increased by the cathepsin K inhibitor ONO-5334, which leads to a robust increase in bone strength: results from a 16-month study in ovariectomised cynomolgus monkeys

S. Nishikawa, H. Yamada, Makoto Tanaka, 2018, Journal of Bone and Mineral Metabolism.

Effect of Intermittent and Daily Regimens of Minodronic Acid on Bone Metabolism in an Ovariectomized Rat Model of Osteoporosis

H. Yamada, Makoto Tanaka, Y. Ochi, 2014, Calcified Tissue International.